AVE avecho biotechnology limited

Ann: Licensing Webinar and Presentation, page-85

  1. 5,188 Posts.
    lightbulb Created with Sketch. 9645
    so as far as time to interim

    221 approx to be dosed
    complete successful screen on recruits as per above to fulfill interim number
    2 to 3 week baseline + 8 week dosing + 2 week washout + data analysis and pulling together the evidence packet = interim results mid to late Q1 2026 seems about right

    just my opinion
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $12.69M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $125 31.29K

Buyers (Bids)

No. Vol. Price($)
40 28068082 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14243308 17
View Market Depth
Last trade - 13.54pm 16/06/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.